| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/07/1999 | WO1999000010A2 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | WO1998045408A3 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 01/07/1999 | WO1998044141A3 Insect expression vectors |
| 01/07/1999 | WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998037100A3 Therapeutic use of the smr1 protein and active derivatives thereof |
| 01/07/1999 | WO1998035984A3 Compositions and methods for highly efficient transfection |
| 01/07/1999 | WO1998032853A3 Secreted proteins and polynucleotides encoding them |
| 01/07/1999 | WO1998028333A3 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889125A1 Monoclonal antibody 4G8b4b12 to human FLT3/FLK2 |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889121A1 Cancer cells capable of tumorigenesis but incapable of infiltration and metastasis, process for preparing the same, and method for screening gene relating to metastasis by using the same |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0889054A2 Antibody 67D2 against CD164 |
| 01/07/1999 | EP0889053A2 Uses of BK-RiV preparations, process for their production and proteins comprised therein |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888777A2 Recombinant bovine herpesvirus type 1 polyptpetides and vaccines |
| 01/07/1999 | EP0888541A1 Cryptic peptides and method for their identification |
| 01/07/1999 | EP0888456A2 Prostate specific antigen oligo-epitope peptide |
| 01/07/1999 | EP0888454A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 01/07/1999 | EP0888453A1 Clostridium perfringens vaccines |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888451A1 Use of viral cis-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites |
| 01/07/1999 | EP0888386A1 Stable factor viii/ von willebrand factor complex |
| 01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
| 01/07/1999 | EP0888384A2 Conjugate for modifying interactions between proteins |
| 01/07/1999 | EP0888383A1 Anti-inflammatory peptides derived from c-reactive protein |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888131A1 Method for removing unconventional transmissible agents from a protein solution |
| 01/07/1999 | EP0888124A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888120A1 Hla binding peptides and their uses |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0888046A1 Method of protein production using mitochondrial translation system |
| 01/07/1999 | EP0784632B1 Process for extracting high-purity von willebrand factor |
| 01/07/1999 | EP0719282B1 Aids and sle prophylactics |
| 01/07/1999 | EP0698040A4 Lhrh antagonists |
| 01/07/1999 | EP0672127B1 Use of thiol redox proteins for reducing disulfide bonds |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/07/1999 | EP0646015B1 Contraceptive vaccine |
| 01/07/1999 | EP0625195B1 Therapy of central nervous system by genetically modified cells |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | EP0587788B1 Methods and compositions of genetic stress response systems |
| 01/07/1999 | EP0528841B1 A method for the preparation of pyridoxylated hemoglobin |
| 01/07/1999 | EP0525076B1 Recombinant bile salt activated lipases |
| 01/07/1999 | DE19748287A1 Indirect measurement of interferon levels in vivo by determining content of Mx proteins |
| 01/07/1999 | DE19728958A1 New primers for detecting the Fox gene that determines coat colour in horses |
| 01/07/1999 | CA2427749A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 01/07/1999 | CA2295326A1 Cardiotrophin-like cytokine |
| 01/07/1999 | CA2295318A1 Human extracellular matrix proteins |
| 01/07/1999 | CA2295315A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | CA2295305A1 Neuronal stem cell gene |
| 01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | CA2295301A1 Plant and viral promoters |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2294704A1 Protein that binds trail |
| 01/07/1999 | CA2294604A1 Transgenic animals expressing human fc receptors |
| 01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
| 01/07/1999 | CA2294131A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | CA2292379A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/07/1999 | CA2290718A1 Improved bacillus thuringiensis toxin |
| 01/06/1999 | CN1204370A A funguns wherein areA, pepC and/or pepE genes have been inactivated |
| 01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
| 01/06/1999 | CN1204367A Antifungal proteins |
| 01/06/1999 | CN1204366A Antifungal protein |
| 01/06/1999 | CN1204364A Production of water stress or salt stress tolerant transgenic cereal plants |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1204343A Endothelial cell proliferation inhibitor and method of use |
| 01/06/1999 | CN1204341A Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1203921A Membrane protein polypeptide having pre-B cell growth-supporting ability and gene thereof |
| 01/06/1999 | CN1203920A Method for producing recombinant human interleukin-6 |
| 01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
| 01/05/1999 | US5856458 Isolated nucleotide sequence |
| 01/05/1999 | US5856457 To obtain dna encoding pf4a receptors, and to express them in host cells. |
| 01/05/1999 | US5856456 Connecting polypeptides |
| 01/05/1999 | US5856452 Oil bodies and associated proteins as affinity matrices |
| 01/05/1999 | US5856449 Glycoprotein |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856447 Vaccine against lyme disease |
| 01/05/1999 | US5856445 Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator |
| 01/05/1999 | US5856444 Physiologically active substance having activity in acting on the megakaryocyte-platelet system, in promoting differentiation,maturation, and/or proliferation therein, and in promoting the formation of platelets, and in promoting the |
| 01/05/1999 | US5856443 Molecular cloning and expression of G-protein coupled receptors |
| 01/05/1999 | US5856442 Relates to a procedure for obtaining immunomodulating soluble proteins. |
| 01/05/1999 | US5856441 Serrate fragments and derivatives |
| 01/05/1999 | US5856440 Solid phase process for synthesizing thymosin α1 |
| 01/05/1999 | US5856438 Its gram-negative bactericidal properties and its ability to bind to and neutralize lps, treatment of mammals suffering from diseases caused by gram-negative bacteria |
| 01/05/1999 | US5856437 Genetic engineering |
| 01/05/1999 | US5856435 Gene therapy; transferring nucleic acids |
| 01/05/1999 | US5856310 Inhibition of farnesyltransferase |